Benfotiamine can help diabetics protect delicate microvessels. Much of the damage of diabetes is caused when glucose-derived compounds, called triosephosphates, accumulate in small vessels. Transketolase, turns these toxic compounds into harmless chemicals that can be removed from the body. benfotiamine increases transketolase activity, thus reducing or eliminating the complications associated with diabetes.
Administration of benfotiamine helped to prevent retinopathy in test subjects with diabetes. Study subjects who received benfotiamine for 36 weeks demonstrated completely normalized levels of damaging toxins in the retina, preventing or delaying the onset of diabetic retinopathy.
In a 24-week study, benfotiamine was shown to improve kidney function. This was shown by a 50% reduction of toxin levels in the kidneys, and a reduction in oxidative stress associated with diabetes. Subjects exhibited a 70-80% inhibition in the development of microalbuminuria, protein in the urine that serves as an early sign of kidney dysfunction.
Benfotiamine mitigates oxidative stress in the eyes, the kidneys, the heart, and even the brain that typically occur with diabetes. Researchers conclude that benfotiamine may offer critical protection for the delicate nerves of the eyes, the kidneys, the peripheral limbs, the heart and the brain by shielding them from damage caused by diabetes.


Chat live with








